Evidence map›Paper›PMID 26606652›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2016

Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture.

Marta E Alarcón-Riquelme, Julie T Ziegler, Julio Molineros, Timothy D Howard, Andrés Moreno-Estrada, Elena Sánchez-Rodríguez, Hannah C Ainsworth, Patricia Ortiz-Tello, Mary E Comeau, Astrid Rasmussen and 35 more

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 7 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 7 syntheses or guidelines pooled it, 163 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Cross-phenotype analysis of Immunochip data identifiesAnnals of the rheumatic diseases · 2018
    Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Observational
  12. Article
  13. Variants inInternational journal of molecular sciences · 2026
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 20 institutions in 7 countries.

Marta E Alarcón-RiquelmeOklahoma Medical Research Foundation, Oklahoma City.
Julie T ZieglerWake Forest School of Medicine, Winston-Salem, North Carolina.
Julio MolinerosOklahoma Medical Research Foundation, Oklahoma City.
Timothy D HowardWake Forest School of Medicine, Winston-Salem, North Carolina.
Andrés Moreno-EstradaStanford University School of Medicine, Stanford, California, and Laboratorio Nacional de Genómica para la Biodiversidad, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Irapuato, Mexico.
Elena Sánchez-RodríguezIcahn School of Medicine at Mount Sinai, New York, New York.
Hannah C AinsworthWake Forest School of Medicine, Winston-Salem, North Carolina.
Patricia Ortiz-TelloStanford University School of Medicine, Stanford, California, and Laboratorio Nacional de Genómica para la Biodiversidad, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Irapuato, Mexico.
Mary E ComeauWake Forest School of Medicine, Winston-Salem, North Carolina.
Astrid RasmussenOklahoma Medical Research Foundation, Oklahoma City.
Jennifer A KellyOklahoma Medical Research Foundation, Oklahoma City.
Adam AdlerOklahoma Medical Research Foundation, Oklahoma City.
Eduardo M Acevedo-VázquezHospital Nacional Guillermo Almenara Irigoyen, Lima, Peru.
Jorge Mariano Cucho-VenegasHospital Nacional Guillermo Almenara Irigoyen, Lima, Peru.
Ignacio García-De la TorreHospital General de Occidente, Zapopan, Mexico.
Mario H CardielCentro de Investigación Clínica de Morelia, Morelia, Mexico.
Pedro MirandaCentro de Estudios Reumatológicos, Santiago, Chile.
Luis J CatoggioHospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Marco Maradiaga-CeceñaHospital General de Culiacán, Culiacán, Mexico.
Patrick M GaffneyOklahoma Medical Research Foundation, Oklahoma City.
Timothy J VyseKing's College London, London, UK.
Lindsey A CriswellUniversity of California, San Francisco.
Betty P TsaoUniversity of California, Los Angeles.
Kathy L SivilsOklahoma Medical Research Foundation, Oklahoma City.
Sang-Cheol BaeHanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.
Judith A JamesOklahoma Medical Research Foundation and University of Oklahoma Health Sciences Center, Oklahoma City.
Robert P KimberlyUniversity of Alabama at Birmingham.
Kenneth M KaufmanCincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
John B HarleyCincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Jorge A Esquivel-ValerioHospital Universitario Dr. José Eleuterio González Universidad Autonoma de Nuevo León, Monterrey, Mexico.
José F MoctezumaHospital General de México, Mexico City, Mexico.
Mercedes A GarcíaHospital Interzonal General de Agudos General San Martin, La Plata, Argentina.
Guillermo A BerbottoHospital Escuela Eva Perón, Granadero Baigorria, Argentina.
Alejandra M BabiniHospital Italiano de Córdoba, Córdoba, Argentina.
Hugo ScherbarthHospital Interzonal General de Agudos Oscar E. Alende, Mar del Plata, Argentina.
Sergio TolozaHospital Interzonal San Juan Bautista, San Fernando del Valle de Catamarca, Argentina.
Vicente BacaHospital de Peditaria, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Swapan K NathOklahoma Medical Research Foundation, Oklahoma City.
Carlos Aguilar SalinasInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Lorena OrozcoInstituto Nacional de Medicina Genómica, Mexico City, Mexico.
Teresa Tusié-LunaInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán and Instituto de Investigaciones Biomédicas de la Universidad Nacional Autónoma de México, Mexico City, Mexico.
Raphael ZidovetzkiUniversity of California, Riverside.
Bernardo A Pons-EstelSanatorio Parque, Rosario, Argentina.
Carl D LangefeldWake Forest School of Medicine, Winston-Salem, North Carolina.
Chaim O JacobUniversity of Southern California School of Medicine, Los Angeles.
Oklahoma Medical Research Foundation · USWake Forest University · USCincinnati Children's Hospital Medical Center · USHospital Base Guillermo Almenara Irigoyen · PEInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXCentro Científico Tecnólogico - Rosario · ARCentro de Estudios Científicos · CLCentro Medico Nacional Siglo XXI · MXEl Hospital General de Agudos Carlos G. Durand · ARHanyang University Seoul Hospital · KRHospital General de México · MXHospital Italiano de Buenos Aires · ARIcahn School of Medicine at Mount Sinai · USInstituto Tecnológico Superior de Irapuato · MXKing's College London · GBNational Institute of Genomic Medicine · MXNational University of General San Martín · ARServicio Diabetología Hospital Córdoba · ARStanford University · USUniversidad Autónoma de Nuevo León · MX

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI PAUL G SPICER · 2013 to 2026
$68.2M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
Program Project in the Genetics of SLEP01AR049084 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2002 to 2012
$12.7M
The Interplay of Sociodemographic and Genetic Factors in SLE Health DisparitiesP60AR053308 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRISWELL, LINDSEY ANN · 2006 to 2016
$11.8M
SequencingP01AI083194 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KIMBERLY, ROBERT P. · 2009 to 2013
$9.6M
HLA GENE COMPLEMENTATION IN PRIMARY SJOGREN'S AND LUPUSR01AI024717 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KOTTYAN, LEAH CLAIRE, WEIRAUCH, MATTHEW TYSON · 1987 to 2025
$7.8M
SNP Confirmation and High Throughput Genotyping CoreP30AR053483 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GUTHRIDGE, JOEL MARVIN · 2007 to 2017
$6.7M
Pre-Clinical Studies to Identify SLE Therapeutic TargetsU19AI082714 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JAMES, JUDITH A · 2009 to 2018
$6.2M
Quantitative Analysis Core P30GM110766 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI CAPRA, J DONALD · 2014 to 2018
$6.1M
CHROMOSOME REGIONS LINKED TO SLE IN MULTIPLEX FAMILIESR01AR043814 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TSAO, BETTY P · 1997 to 2012
$5.7M
Science in a Culture of MentoringP30GM103510 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JAMES, JUDITH A · 2012 to 2016
$3.9M
SLE Susceptibility and Clinical Significance at 2q22-24 across Multiple EthnicitiR01AR060366 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI NATH, SWAPAN K. · 2010 to 2019
$3.3M
NCATS NIH HHS UL1 TR001417NCI NIH HHS R01 CA141700NCI NIH HHS R01-CA-141700NIAID NIH HHS P01 AI083194NIAID NIH HHS P01-AI-083194NIAID NIH HHS R01 AI024717NIAID NIH HHS R21 AI107176NIAID NIH HHS R21-AI-107176NIAID NIH HHS U01 AI101934NIAID NIH HHS U19 AI082714NIAMS NIH HHS P01 AR049084NIAMS NIH HHS P01-AR-049084NIAMS NIH HHS P30 AR053483NIAMS NIH HHS P30-AR-053483NIAMS NIH HHS P60 AR053308NIAMS NIH HHS R01 AR043814NIAMS NIH HHS R01-AR-043814NIAMS NIH HHS R01 AR057172NIAMS NIH HHS R01-AR-057172NIAMS NIH HHS R01 AR060366NIAMS NIH HHS R01-AR-060366NIAMS NIH HHS R21 AR065626NIAMS NIH HHS R21-AR-065626NIAMS NIH HHS RC1 AR058621NIAMS NIH HHS RC1-AR-058621NIGMS NIH HHS P30 GM103510NIGMS NIH HHS P30-GM-103510NIGMS NIH HHS P30 GM110766NIGMS NIH HHS U54 GM104938NIGMS NIH HHS U54-GM-104938PHS HHS U01-A101934PHS HHS U19-A1082714
6 · The paper itself

Abstract

objectiveSystemic lupus erythematosus (SLE) is a chronic autoimmune disease with a strong genetic component. We undertook the present work to perform the first genome-wide association study on individuals from the Americas who are enriched for Native American heritage.

methodsWe analyzed 3,710 individuals from the US and 4 countries of Latin America who were diagnosed as having SLE, and healthy controls. Samples were genotyped with HumanOmni1 BeadChip. Data on out-of-study controls genotyped with HumanOmni2.5 were also included. Statistical analyses were performed using SNPtest and SNPGWA. Data were adjusted for genomic control and false discovery rate. Imputation was performed using Impute2 and, for classic HLA alleles, HiBag. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated.

resultsThe IRF5-TNPO3 region showed the strongest association and largest OR for SLE (rs10488631: genomic control-adjusted P [Pgcadj ] = 2.61 × 10(-29), OR 2.12 [95% CI 1.88-2.39]), followed by HLA class II on the DQA2-DQB1 loci (rs9275572: Pgcadj  = 1.11 × 10(-16), OR 1.62 [95% CI 1.46-1.80] and rs9271366: Pgcadj  = 6.46 × 10(-12), OR 2.06 [95% CI 1.71-2.50]). Other known SLE loci found to be associated in this population were ITGAM, STAT4, TNIP1, NCF2, and IRAK1. We identified a novel locus on 10q24.33 (rs4917385: Pgcadj  = 1.39 × 10(-8)) with an expression quantitative trait locus (eQTL) effect (Peqtl  = 8.0 × 10(-37) at USMG5/miR1307), and several new suggestive loci. SLE risk loci previously identified in Europeans and Asians were corroborated. Local ancestry estimation showed that the HLA allele risk contribution is of European ancestral origin. Imputation of HLA alleles suggested that autochthonous Native American haplotypes provide protection against development of SLE.

conclusionOur results demonstrate that studying admixed populations provides new insights in the delineation of the genetic architecture that underlies autoimmune and complex diseases.

Indexed as

American Indian or Alaska NativeArgentinabeta KaryopherinsCase-Control StudiesCD11b AntigenChileChromosomes, Human, Pair 10DNA-Binding ProteinsFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHaplotypesHLA-DQ AntigensHLA-DQ beta-ChainsHumansInterferon Regulatory FactorsATP5MK protein, humanbeta KaryopherinsCD11b AntigenDNA-Binding ProteinsHLA-DQA2 antigenHLA-DQ AntigensHLA-DQB1 antigenHLA-DQ beta-ChainsInterferon Regulatory FactorsInterleukin-1 Receptor-Associated KinasesIRAK1 protein, humanIRF5 protein, humanITGAM protein, humanMitochondrial Proton-Translocating ATPasesNADPH OxidasesNCF2 protein, humanSTAT4 protein, humanSTAT4 Transcription FactorTNIP1 protein, humanTNPO3 protein, human

Identifiers

PMID26606652
PMCPMC4829354
OpenAlexW2338966394

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.